Table 2.
WHO Criteria | ADA Criteria | |||
---|---|---|---|---|
Prediabetes [25] | Glucose | Fasting plasma glucose | 110–125 mg/dL (6.1–6.9 mmol/L) |
100–125 mg/dL (5.6–6.9 mmol/L) |
Random Plasma Glucose | ND | Not applicable | ||
2-h plasma glucose (OGTT) | 140–200 mg/dL (7.8–11.0 mmol/L) |
140–200 mg/dL (7.8–11.0 mmol/L) |
||
Hemoglobin A1c | ND | 5.7–6.4% | ||
Impaired glucose tolerance [26] | Glucose | 2-h plasma glucose (OGTT) | ND | 140–199 mg/dL (7.8–11.0 mmol/L) |
Type 2 Diabetes Mellitus [25,26] | Glucose | Fasting plasma glucose | ND | ≥126 mg/dL (7.0 mmol/L) |
Random Plasma Glucose | ND | ≥200 mg/dL (11.1 mmol/L) |
||
2-h plasma glucose (OGTT) | ND | ≥200 mg/dL (11.1 mmol/L) |
||
Hemoglobin A1c | ND | ≥6.5% |
ADA: American Diabetes Association; Fasting plasma glucose: fasting for at least 8 h with no calorie intake; OGTT (2-h plasma glucose): OGTT using a load of glucose 1.75 g/kg of body weight, with a maximum of 75 g; Random plasma glucose: In patients with hyperglycemic crises or classic symptoms of hyperglycemia (e.g., polyuria, polydipsia); diabetes: In the absence of unequivocal hyperglycemia, diagnosis is confirmed if two different tests are above threshold or a single test is above threshold twice; A1c: glycosylated hemoglobin; OGTT: Oral Glucose Tolerance Test; ND: Not Declared; WHO: World Health Organization.